pharmaceutical investing ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement
pharmaceutical investing ACADIA Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for NUPLAZID (Pimavanserin)
NorthStar Gaming Announces Grant of Equity Incentive Awards to Non-Executive Directors in Lieu of Cash Compensation